The novel natural antibiotics pyloricidin A, B and C, which possess potent and highly selective anti-Helicobacter pylori activity, were synthesized from D-galactosamine as a chiral template for the common (2S,3R,4R,5S)-5-amino-2,3,4,6-tetrahydroxyhexanoic acid moiety. The synthetic strategy, using 2-amino-2-deoxyuronic acid derivatives as key intermediates, was stereochemistry on the 5-amino-2,3,4,6-tetrahydroxyhexanoic acid moiety. From the drastic stereochemistry of the 5-amino-2,3,4,6-tetrahydroxyhexanoic acid moiety were significant for the activity.
Helicobacter pylori is a Gram-negative bacterium that was isolated from the mucus layer of human gastric epithelium in 1983.1) Since its discovery, continuous research has been made to investigate the relationships between infection with this organism and peptic ulcers. As a result, it has been widely accepted that H. pylori infection is a major cause of gastric and duodenal ulcers and eradication of this organism results in a drastic decrease in the recurrence rate in peptic ulcer patients.2,3) Recent research has revealed that H. pylori infection is also associated with gastric cancer.4-6) Therefore, eradication of H. pylori has become an important topic in the field of gastroenterology. In 1994, the National Institute of Health consensus conference concluded that all ulcer patients with H. pylori infection should be treated with eradication therapy. 7) H. pylori has susceptibility to a variety of antimicrobial agents,8-10) however, successful eradication could not be achieved by single administration of these agents.11) Accordingly, dual therapies or triple therapies, concomitant administration of antimicrobial agents and a proton pump inhibitor, are prevalent for the purpose of eradicating H. pylori, and eradication rates of over 80% have been reported.11-13) However, single agent therapy is preferable for patient compliance and fewer side effects.
In our program to develop an efficient anti-H. pylori agent, the novel antibiotics pyloricidin A, B and C were discovered from the fermentation broth of Bacillus sp.
HC-70 in Takeda's pharmaceutical discovery center.
They possess unique structures consisting of a novel (2S,3R,4R,5S)-5-amino-2,3,4,6-tetrahydroxyhexanoic acid phenylalanine). 14) In addition, they were found to have potent and highly selective anti-H. pylori activity. 15 ) From these findings, they were expected to eradicate H. pylori without disturbing the gastrointestinal microflora. Their unique structures and antibacterial profiles made them important lead compounds for therapeutically useful anti-H. pylori agents. In order to investigate structure activity relationships on the common (2S,3R,4R,5S)-5-aminowas required to develop a convenient synthesis of pyloricidin A, B and C which would be applicable for the preparation of modified derivatives. In this paper, we wish to describe the total synthesis of pyloricidin A, B and C, as well as their application in the study of pyloricidin derivatives.
Chemistry
The synthesis of pyloricidin A, B and C is shown in Scheme 1. We selected D-galactosamine as a chiral template for the (2S,3R,4R,5S)-5-amino-2,3,4,6tetrahydroxyhexanoyl moiety, because it had all the correct stereocenters required to construct the moiety. Benzyl 2- benzyl groups of 7a-c was effected by hydrogenolysis in an acidic media (pH 2.0) to give 8a-c, which were subsequently treated with sodium borohydride to afford the protected pyloricidins 9a-c. Finally, removal of Boc protecting group with TFA and saponification followed by purification by high porous polymer (MCI gel CHP-20P) column chromatography and recrystallization afforded 10a-c.
Utilizing the synthetic procedure described above,
The epimer 21 of pyloricidin C, with an (S)configuration at the C-3 position on the 5-amino-2,3,4,6tetrahydroxyhexanoyl moiety, was also prepared as shown in Scheme 3. D-Glucosamine 14 was transformed into the was converted to 21 by a similar procedure to that employed for the preparation of 10c.
Results and Discussion
The physicochemical data of 10a-c are listed in Table 1 .
NMR spectra and the HPLC retention times of 10a-c were in complete accord with those of natural pyloricidin A, B
and C. Previously, the absolute configuration of the 5amino-2,3,4,6-tetrahydroxyhexanoic acid moiety was determined by X-ray diffraction and Mosher's method20) applied to the derivatives with that moiety ( 25, instead of the desired compound 24, was found to be the major product of the condensation reaction. Therefore
we prepared 13a-f by the synthetic procedure described above for pyloricidin C (10c). In addition, this synthetic procedure was applicable to the synthesis of the epimer 21 of pyloricidin C, using D-glucosamine as the starting material. On the basis of these results, we concluded that the synthetic strategy via the 2-amino-2-deoxyuronic acid derivative 4 (or 17) was convenient and effective not only for the preparation of pyloricidin A, B and C but also for pyloricidin derivatives. The anti-H. pylori activity of 13a-f and 21 against four clinical isolates (NCTC11637, CPY433, TN2 and TN58) is shown in Table 2 . As a reference, the anti-H. pylori activity of synthetic pyloricidin C (10c) is also listed. Compound 10 c displayed potent anti-H. pylori activity in the range of resulted in marked decrease of the activity. In addition, introduction of a methyl group into the benzene ring (13e) or inversion of the chiral center (13f) also lowered the activity. Furthermore, the epimer 21 showed weak activity. 
Conclusion
We achieved the total synthesis of the novel antibiotics pyloricidin A, B and C from D-galactosamine as a chiral template for the (2S,3R,4R,5S)-5-amino-2,3,4,6tetrahydroxyhexanoic acid moiety. The synthetic strategy employed in this work was also useful for the preparation of pyloricidin derivatives. The anti-H. pylori activity of the pyloricidin derivatives (13a-f and 21) revealed that the Compound 10b and 10c were obtained by the similar procedure employed for the preparation of 10a in 60 and 64% yields. Their physicochemical data are listed in Table 1 . palladium on charcoal (80mg) in MeOH (10ml) was vigorously stirred under an atmosphere of hydrogen at room temperature for 1 hour. The mixture was filtered and the filtrate was concentrated under reduced pressure and the residue was dissolved in DMF (5ml). To the solution were added Boc-L-Leu (84mg, 0.34mmol), HOBt (50mg, 0.37 mmol) and DCC (76mg, 0.37mmol). After being stirred at room temperature for 2 hours, the reaction mixture was concentrated under reduced pressure. The residue was extracted with EtOAc and H2O. The organic layer was washed with 5% aqueous citric acid, saturated aqueous NaHCO3 and brine, dried over Na2SO4, filtered and then concentrated. The residue was chromatographed on silica gel with EtOAc as an eluent and recrystallized from isopropyl ether to give 12a (130mg, 66%) as a colorless solid. Compound 12b-f were obtained by the similar procedure employed for the preparation of 12a. Their physicochemical data are listed in Table 3 .
N-[(2S,3R,4R,5S)-5-L-Leucylamino-2,3,4,6tetrahydroxyhexanoyl]glycine (13a) A solution of 12a (60mg, 0.10mmol) in MeOH (5ml)-H2O (1ml) was adjusted to pH 2.0 with 1N HCl and then 10% palladium on charcoal (50mg) was added to the solution. The mixture was vigorously stirred under an atmosphere of hydrogen at room temperature for 5 hours and filtered. The filtrate was neutralized with 1N NaOH and evaporated to dryness under reduced pressure. The residue was dissolved in MeOH (5ml) and sodium borohydride (10 mg, 0.26mmol) was added to the solution. After being stirred at room temperature for 30 minutes, the mixture was evaporated under reduced pressure. The residue was dissolved in TFA (5ml) and the solution was stirred at room temperature for 30 minutes and then evaporated. The residue was dissolved in H2O (1ml)-1N NaOH (0.5ml) and stirred at room temperature for 1 hour and then neutralized with 1N HCl. After removal of solvent under reduced pressure, the residue was purified by CHP-20P (20 ml) column chromatography with H2O (150ml) as an eluent and recrystallized from EtOH to give 13a (30mg, 81%) as a colorless solid. Compound 13b-f were obtained by the similar procedure employed for the preparation of 13a. Their physicochemical data are listed in Table 3 .
2-Carbobenzyloxyamino-2-deoxy-D-glucopyranose (15)
To a solution of D-glucosamine hydrochloride 14 (7.0g, 33mmol) in H2O (200ml) were added NaHCO3 (8.20g, 97.5mmol) and carbobenzoxy chloride (5.54g, 32.5mmol).
After being stirred at room temperature for 2 hours, the reaction mixture was extracted with THF-EtOAc (2:1, 300 Na2SO4, filtered and then concentrated under reduced pressure.
The residue was recrystallized from isopropyl palladium on charcoal (50mg) in MeOH (20ml) was vigorously stirred under an atmosphere of hydrogen at room temperature for 2 hours. The mixture was filtered and the filtrate was concentrated under reduced pressure and the residue was dissolved in DMF (5ml). To the solution were added Boc-L-Leu (78mg, 0.31mmol), HOBt (49mg, 0.36 mmol) and DCC (59mg, 0.29mmol) and the mixture was stirred at room temperature for 18 hours and concentrated.
The residue was extracted with EtOAc and H2O. The organic layer was washed with 5% aqueous citric acid, saturated aqueous NaHCO3 and brine, dried over Na2SO4, filtered and then concentrated. The residue was Bacterial suspensions of approximately 106cfu/ml were applied to the brucella agar plates supplemented with 7% horse blood containing twofold serial dilutions of test atmosphere containing 5% O2, 10% CO2 and 85% N2.
MICs were defined as the lowest concentrations of the compounds preventing visible bacterial growth after four days of incubation.
